News

How do doctors guide their patients to work effectively despite the breathing disorder or seek modifications to their job ...
Patients with COPD and chronic hypercapnic respiratory failure on noninvasive ventilation report similar quality of life ...
The Ministry of Health is inviting residents affected by asthma or COPD to complete patient care surveys to help improve respiratory care and support Bermuda’s integrated health strategy. A Government ...
Having recently scored approval for Nucala in chronic obstructive pulmonary disease (COPD), GSK has now signed a major ...
GSK and Hengrui Pharma signed a global deal for up to 12 drugs, including COPD therapy, with milestone payments totaling $12 ...
"While COPD remains the third leading cause of death worldwide, patients and families have limited treatment options for ...
After scoring U.S. states on lung health-related environmental and behavioral factors, Colorado and Hawaii emerged as the ...
The annual Best Hospitals report from US News & World Report compares more than 4,500 hospitals across 15 specialties and 22 ...
The two companies have entered into an agreement to develop respiratory, immunology, inflammation, and cancer therapies.
– Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD – – Broadens global development ...
Britain's GSK and China's Jiangsu Hengrui Pharmaceuticals have agreed on a $500 million deal to develop up to a dozen new ...
Tozorakimab, an anti-IL-33 antibody, improves lung function and may reduce exacerbations in high-risk COPD patients, early ...